LAB Research completes major expansion of its Canadian facility ahead of schedule

    - 122% increase in vivarium housing capacity
    - 88% increase in square footage
    - Inhalation toxicology, drug metabolism and bioanalytical services added
    - Projected 200% increase in revenue generating capacity
    - One hundred new employees added, all key positions filled.

    LAVAL, QC, Sept. 30 /CNW Telbec/ - LAB Research Inc. ("LRI" or "LAB
Research") (TSX: LRI), a Canadian-based global non-clinical contract research
organization, is pleased to announce that it has completed the first phase of
a 3-year $40 million facility expansion of its Canadian operations.
    LAB Research's Canadian facilities will now total 156,000 ft(2) and
feature 80 rooms representing increases of 88% and 122% respectively. To date
$24 million has been invested as part of this 3-year expansion plan. LRI
expects to invest a further $16 million in equipments over the course of the
next 2 years as it progressively fills up newly created capacity. The company
will also be offering new services to its global clientele. Bioanalytical and
expanded analytical services will be offered during the next quarter. The new
inhalation toxicology department will be validated for new studies to start
before year-end. The drug metabolism laboratories will offer a full range of
services early in 2009. Vivarium activities will be increased initially from
36 to 55 rooms while the remaining capacity will be made available this coming
    "This expansion represents the largest investment the Company has made to
date. We are now able to offer the desired capacity, improved scheduling
flexibility and larger suite of services to our existing and potential
clients. This investment will bring a much needed critical mass required to
increase our operating margins and help support our continued focus on
scientific excellence," explains Luc Mainville, President and CEO of LAB
Research. "While the expansion will allow us to potentially triple our
Canadian revenues over the coming years, we intend to continue elevating our
scientific contribution and study vigilance to ensure a controlled growth of
our Canadian activities. We have to date, been successful in staffing all key
positions which a large proportion of veteran staff which will contribute to
accelerate the start of the services and to maintain a high level of seniority
throughout the organization." added Mr. Mainville.

    About LAB Research Inc.

    LAB Research is a Canadian global non-clinical contract research
organization that provides contract research services to the pharmaceutical,
biotechnology, agro-chemical, petro-chemical and industrial markets. LAB
Research supports the development of its customers' products from three
state-of-the-art facilities located in Canada, Denmark and Hungary. LAB
Research's shares trade on the TSX under the symbol "LRI", with 18.1 million
shares outstanding.
    %SEDAR: 00023798EF

For further information:

For further information: Luc Mainville, Chief Executive Officer, LAB
Research Inc., (450) 973-2240, Ext.: 1206,; Media
and Investor: Dominic Sicotte, Echoes Financial Network Inc., (866) 633-9551,
(514) 842-9551,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890